Clinical Trials Sponsored by Kerwin Research Center, LLC

Total 396 results

H. Lee Moffitt Cancer Center and Research Institute
Minneamrita Therapeutics LLC

Terminated

Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States
Sarcoma Oncology Research Center, LLC
Aadi Bioscience, Inc.

Completed

Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers

Melanoma | Renal Cell Carcinoma | Hepatocellular Carcinoma | Colorectal Cancer | Ewing Sarcoma | Non Small Cell Lung Cancer | Chordoma | Urothelial Carcinoma | Classical Hodgkin Lymphoma | PEComa | Desmoid Tumor | Epithelioid Sarcoma | Squamous Cell Carcinoma | MTOR Activating Mutation

United States
Centre Jean Perrin
National Cancer Institute, France; ARC Foundation for Cancer Research

Completed

Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma (GLYRad)

Adult Glioblastoma

France
Sarcoma Oncology Research Center, LLC
Bristol-Myers Squibb

Recruiting

SAINT:Trabectedin, Ipilimumab and Nivolumab as First Line Treatment for Advanced Soft Tissue Sarcoma

Advanced Soft Tissue Sarcoma | Metastatic Soft Tissue Sarcoma

United States
USDA, Western Human Nutrition Research Center
Sonomaceuticals LLC

Completed

Metabolic Response to Chardonnay Grape Marc Powder

Obesity | Dyslipidemia

United States
Bayer
Janssen Research & Development, LLC; Colorado Prevention Center

Completed

Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities (VOYAGER PAD)

Peripheral Artery Disease

Poland, Belgium, France, Spain, China, Korea, Republic of, United States, Switzerland, Estonia, Portugal, Japan, Hungary, Canada, Netherlands, Finland, Austria, United Kingdom, Germany, Czechia, Thailand, Brazil, Denmark, Italy, Russian... and more
ERLINDA M GORDON

Recruiting

LINNOVATE: Lurbinectedin, Ipilimumab and Nivolumab for Soft Tissue Sarcoma (LINNOVATE)

Advanced Soft-tissue Sarcoma

United States
National Research Center for Hematology, Russia
Enrollme.ru, LLC; Foundation for Cancer Research Support (RakFond)

Completed

Registry of Patients With Hematologic Disease and COVID-19 in Russia (CHRONOS19)

Coronavirus Infection and Hematologic Diseases

Russian Federation
Charite University, Berlin, Germany
German Federal Ministry of Education and Research; Center for Stroke Research...

Completed

Patient Satisfaction in Stroke Patients (PatZuFrie)

Stroke

Germany
Charite University, Berlin, Germany
NeuroCure Clinical Research Center, Charite, Berlin; Department of Surgery,... and other collaborators

Active, not recruiting

Influence of Minimally Invasive Thymectomy on the Subsequent Clinical Course of Myasthenia Gravis

Myasthenia Gravis

Germany
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC; Janssen Scientific Affairs, LLC

Terminated

Ibrutinib and PD-1 Blockade in High Risk Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

United States
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC; Janssen Scientific Affairs, LLC

Completed

Pembrolizumab in Combination With Ibrutinib for Advanced, Refractory Colorectal Cancers

Colorectal Cancer | Colon Cancer | Colorectal Carcinoma | Colon Disease

United States
LEC Eye Centre
Alcon Research

Completed

Visual Outcomes Following Bilateral Implantation of the Vivity Toric Intraocular Lens

Cataract Senile | Intraocular Lens Complication

Malaysia
Charite University, Berlin, Germany
NeuroCure Clinical Research Center, Charite, Berlin; Siemens Health Care

Completed

Prediction of Stroke-associated Pneumonia (PREDICT)

Ischemic Stroke

Spain, Germany
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Active, not recruiting

Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC)

Lung Cancer | Non-small Cell Lung Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Completed

Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas

Malignant Glioma

United States
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Completed

Dose Dense Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Ovarian Cancer

Ovarian Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Completed

Preparedness Study - HPV Vaccine

Sexual Transmission of Infection

United States, South Africa
H. Lee Moffitt Cancer Center and Research Institute
Trod Medical, US,LLC

Completed

Pilot Study on Focal Prostate Radio-Frequency Ablation

Prostate Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Completed

A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma

Glioblastoma

United States
Charite University, Berlin, Germany
Prof. Dr. Jochen Fiebach, Center for Stroke Research Berlin (CSB), Charité...

Unknown

Dual AntiPlatelet Therapies for Prevention of Periinterventional Embolic Events in TAVI (DAPT-TAVI)

Aortic Valve Stenosis | Transcatheter Aortic Valve Replacement | Intracranial Embolism
Sidney Kimmel Comprehensive Cancer Center at Johns...
Janssen Research & Development, LLC

Not yet recruiting

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

Lymphoma | Multiple Myeloma | Hodgkin Lymphoma | Myelofibrosis | Non Hodgkin Lymphoma | Chronic Myeloid Leukemia | Hematologic Malignancy | Aplastic Anemia | Myelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML) | Bone Marrow Transplant Rejection | Acute Lymphoblastic Leukemia (ALL), Adult
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Active, not recruiting

Phase II Study of Pembrolizumab and Lenvatinib in Advanced Well-differentiated Neuroendocrine Tumors

Neuroendocrine Tumors | Neuroendocrine Carcinoma | Neuroendocrine Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Janssen Scientific Affairs, LLC

Active, not recruiting

Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple Myeloma

Multiple Myeloma

United States
H. Lee Moffitt Cancer Center and Research Institute
AstraZeneca; Brooklyn ImmunoTherapeutics, LLC

Active, not recruiting

IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma

Squamous Cell Carcinoma of the Head and Neck | Oropharynx Squamous Cell Carcinoma | Squamous Cell Carcinoma | Oral Cavity Squamous Cell Carcinoma | Metastatic Squamous Cell Carcinoma | Hypopharynx Squamous Cell Carcinoma | Paranasal Sinus Squamous Cell Carcinoma | Larynx Squamous Cell Carcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Completed

Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma

Glioblastoma | Brain Tumor | GBM

United States
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Completed

SARS-CoV-2 (COVID-19) Immune Surveillance Among a Population Based Sample of Adults in Florida

Coronavirus Infection

United States
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Completed

Study of Gardasil in Mid-Adult Males (MAM)

Human Papillomavirus

United States, Mexico
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Completed

Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and Solids

Ovarian Cancer | Endometrial Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Completed

Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer

Breast Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Recruiting

Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma

Ocular Melanoma | Uveal Melanoma

United States
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Recruiting

Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma

Merkel Cell Carcinoma | Neuroendocrine Carcinoma of the Skin | Trabecular Carcinoma of the Skin

United States
Kerry Rogers
Janssen Research & Development, LLC

Withdrawn

Ibrutinib and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia After Ibrutinib Resistance

Chronic Lymphocytic Leukemia | Loss of Chromosome 17p
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Completed

Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma

Melanoma

United States
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Withdrawn

FOLFOX/Bevacizumab +/- MK-0646 in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer
Metabolic Center of Louisiana Research Foundation
Amylin Pharmaceuticals, LLC.

Completed

Exenatide and Metformin Therapy in Overweight Women With PCOS

Polycystic Ovary Syndrome

United States
Janssen Research & Development, LLC
City of Hope Medical Center

Recruiting

A Study of JNJ-90014496 in Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

United States, Australia
The Crofoot Research Center, Inc.
Janssen Scientific Affairs, LLC

Completed

Rapid Reinitiation of a Single Tablet Antiretroviral Therapy Using Symtuza® in HIV-1 Infected Treatment-Experienced Patients Off Therapy. (ReSTART) (ReSTART)

HIV-1-infection

United States
Midwest Center for Metabolic and Cardiovascular...
Pharmavite LLC

Completed

Bioavailability of Select Nutrients From Two Formulations of a Multivitamin/Mineral Supplement

Bioavailability

United States
Midwest Center for Metabolic and Cardiovascular...
Pharmavite LLC

Completed

Bioavailability of EPA + DHA in a SMEDS Formulation

Bioavailability

United States
Perseverance Research Center, LLC
Cerulean Advanced Fitness and Wellness

Completed

Specialized Food Plan Based on Individual Physiological Comprehensive Body Assessments Accompanied With Cellular Repair Therapy to Decrease Inflammation Cognitively Impaired Patients

Alzheimer Disease | Mild Cognitive Impairment

United States
Ludwig Institute for Cancer Research
Xcovery Holding Company, LLC; Cancer Research Institute, New York City; MedImmune...

Completed

Phase 1/2 Study of Ensartinib and Durvalumab, in ALK-rearranged Non-small Cell Lung Cancer

Carcinoma | NSCLC | Non-small Cell Lung Cancer

United States
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC; Cancer Prevention Research Institute of Texas

Recruiting

A Randomized Trial of Maintenance Systemic Therapy After Radiation for Oligometastatic Renal Cell Carcinoma (ASTROs)

Oligometastatic Renal Cell Carcinoma

United States
University of Michigan Rogel Cancer Center
Merck Sharp & Dohme LLC; Hoosier Cancer Research Network

Recruiting

Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer (PLANE-PC)

Neuroendocrine Tumors | Prostate Cancer Metastatic

United States
University of Michigan Rogel Cancer Center
Merck Sharp & Dohme LLC; Hoosier Cancer Research Network

Recruiting

Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas

Cutaneous T Cell Lymphoma | Fungoides Mycosis Sezary Syndrome

United States
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI); Pharmavite LLC; Seafood Industry Research Fund

Active, not recruiting

Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer

Stage I Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer

United States
Centre Jean Perrin
International Cancer Research Group; Institut Max Planck d'optique quantique

Recruiting

Interest of Broadband Spectroscopy Analysis by Infrared Laser on Liquid Biopsies in Breast Cancer Screening (ICRG0101)

BRCA1 Mutation | BRCA2 Mutation | Breast Cancer Female

France
Charite University, Berlin, Germany
German Research Center for Artificial Intelligence

Not yet recruiting

Therapeutic Assistance and Decision-making Algorithms in Hepatobiliary Tumor Boards (ADBoard)

Hepatocellular Carcinoma | Intrahepatic Cholangiocarcinoma | Gallbladder Carcinoma | Cholangiocarcinoma, Perihilar | Fibrolamellar Hepatocellular Carcinoma | Metastasis to Liver

Germany
Providence Health & Services
MedImmune LLC; Providence Cancer Center, Earle A. Chiles Research Institute

Active, not recruiting

Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or Melanoma

Melanoma | Head and Neck Cancer | Carcinoma, Squamous Cell | Head and Neck Squamous Cell Carcinoma | Cell Cancer, Squamous

United States
University of Colorado, Denver
Janssen Research & Development, LLC

Recruiting

Amivantamab With Tyrosine Kinase Inhibitors (TKI) for Advanced NSCLC With ALK, ROS1, or RET Alterations

Lung Cancer | Non Small Cell Lung Cancer

United States

Clinical Trials Sponsored by Kerwin Research Center, LLC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations